Face to Face Hot Stocks: Akebia Therapeutics, Inc. (NASDAQ:AKBA), TCF Financial Corporation (NYSE:TCF)

earning reaction history

Akebia Therapeutics, Inc. (NASDAQ:AKBA)

Akebia Therapeutics, Inc. (NASDAQ:AKBA) closed at $8.83 on the last trading session with an decrease of -0.79%, whereas, it previously closed at $8.9. The company has a market capitalization of $1.06 Billion. The company traded shares of 1.25 Million on the trading day while its three month average volume stands at 1.49 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) produced diluted EPS of -2.43. The EPS estimate for next year as estimated by analysts is at -1.48 while EPS for next quarter is estimated at -0.47. Earnings per Share growth for this year is reported at -46.1, while the analysts estimated the EPS growth for next year at -1.48% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 8.1%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Akebia Therapeutics, Inc. (NASDAQ:AKBA) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Akebia Therapeutics, Inc. (NASDAQ:AKBA) stands at 3.26 and Price to Book or P/B for the most recent quarter stands at 2.25. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Akebia Therapeutics, Inc. (NASDAQ:AKBA) are reported at 0.8 and 1.3 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Akebia Therapeutics, Inc. (NASDAQ:AKBA) stands at -28, -44.8 and -23 respectively

The trailing twelve month Revenue of Akebia Therapeutics, Inc. (NASDAQ:AKBA) is reported at 325.3 Million with income of -245200000. The outstanding shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) are 120 Million. The institutional Ownership of the shares of 71.7 stands at 0.80%, this figure is decreased -1.64 in the last six months. The insider ownership for the shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) is ticked at 0.9%, the figure is rose 15.85% in the last six months.

Some other important financial aspects to be discussed here for Akebia Therapeutics, Inc. (NASDAQ:AKBA) is the Mean Target Price estimated by the analysts which stands at 14.59. The 52 week high of Akebia Therapeutics, Inc. (NASDAQ:AKBA) is placed at 10.53 and 52 week low is standing at 2.99.

Performance wise the shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) fell down -8.88% for the week, it also rise 13.06% for the monthly performance, while for the quarter it went down 109.74%. The shares increase 110.74% for the half year and flew up for the Year-To-Date performance. The shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) grew 23.67% for the yearly performance.

TCF Financial Corporation (NYSE:TCF)

TCF Financial Corporation (NYSE:TCF) closed at $39.16 on the last trading session with an decrease of -1.29%, whereas, it previously closed at $39.67. The company has a market capitalization of $6.08 Billion. The company traded shares of 858752 on the trading day while its three month average volume stands at 991.55 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of TCF Financial Corporation (NYSE:TCF) produced diluted EPS of 3.22. The EPS estimate for next year as estimated by analysts is at 4.75 while EPS for next quarter is estimated at 0.89. Earnings per Share growth for this year is reported at 42.5, while the analysts estimated the EPS growth for next year at 4.75% and Earnings growth for next 5 years stands at 34.3% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 14.2%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of TCF Financial Corporation (NYSE:TCF) is at 12.17 while the forward p/e is at 8.24. The P/S or Price to Sales ratio of TCF Financial Corporation (NYSE:TCF) stands at 5.84 and Price to Book or P/B for the most recent quarter stands at 0.92. The Price to Free Cash Flow ratio or P/FCF is reported at 17.3. The quick ratio and the current ratio of TCF Financial Corporation (NYSE:TCF) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for TCF Financial Corporation (NYSE:TCF) stands at 1, 8.5 and 14.6 respectively

The trailing twelve month Revenue of TCF Financial Corporation (NYSE:TCF) is reported at 1.04 Billion with income of 288.9 Million. The outstanding shares of TCF Financial Corporation (NYSE:TCF) are 155.26 Million. The institutional Ownership of the shares of 85.5 stands at 0.80%, this figure is increased 5.91 in the last six months. The insider ownership for the shares of TCF Financial Corporation (NYSE:TCF) is ticked at 1%, the figure is plummeted -1.19% in the last six months.

Some other important financial aspects to be discussed here for TCF Financial Corporation (NYSE:TCF) is the Mean Target Price estimated by the analysts which stands at 49.93. The 52 week high of TCF Financial Corporation (NYSE:TCF) is placed at 47.46 and 52 week low is standing at 35.96.

Performance wise the shares of TCF Financial Corporation (NYSE:TCF) fell down -7.71% for the week, it also fell -8.7% for the monthly performance, while for the quarter it went up -5.55%. The shares increase 4.71% for the half year and plummeted for the Year-To-Date performance. The shares of TCF Financial Corporation (NYSE:TCF) shrinked -14.57% for the yearly performance.